- Home
- ONMD vs NEUP Comparison
ONMD vs NEUP Comparison
Compare ONMD & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- NEUP
- Stock Information
- Founded
- ONMD 2006
- NEUP 1996
- Country
- ONMD United States
- NEUP United States
- Employees
- ONMD N/A
- NEUP N/A
- Industry
- ONMD
- NEUP
- Sector
- ONMD
- NEUP
- Exchange
- ONMD Nasdaq
- NEUP Nasdaq
- Market Cap
- ONMD 12.8M
- NEUP 12.7M
- IPO Year
- ONMD N/A
- NEUP N/A
- Fundamental
- Price
- ONMD $0.56
- NEUP $7.13
- Analyst Decision
- ONMD
- NEUP Strong Buy
- Analyst Count
- ONMD 0
- NEUP 1
- Target Price
- ONMD N/A
- NEUP $21.00
- AVG Volume (30 Days)
- ONMD 25.4M
- NEUP 26.7K
- Earning Date
- ONMD 05-14-2025
- NEUP 08-15-2025
- Dividend Yield
- ONMD N/A
- NEUP N/A
- EPS Growth
- ONMD N/A
- NEUP N/A
- EPS
- ONMD N/A
- NEUP 0.00
- Revenue
- ONMD $532,000.00
- NEUP $15,662,715.00
- Revenue This Year
- ONMD N/A
- NEUP N/A
- Revenue Next Year
- ONMD N/A
- NEUP N/A
- P/E Ratio
- ONMD N/A
- NEUP $2.30
- Revenue Growth
- ONMD N/A
- NEUP N/A
- 52 Week Low
- ONMD $0.30
- NEUP $2.90
- 52 Week High
- ONMD $1.60
- NEUP $126.00
- Technical
- Relative Strength Index (RSI)
- ONMD 56.14
- NEUP N/A
- Support Level
- ONMD $0.34
- NEUP N/A
- Resistance Level
- ONMD $0.66
- NEUP N/A
- Average True Range (ATR)
- ONMD 0.09
- NEUP 0.00
- MACD
- ONMD 0.02
- NEUP 0.00
- Stochastic Oscillator
- ONMD 40.17
- NEUP 0.00
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.